Cytyc and Digene extend deadline again:
This article was originally published in Clinica
Executive Summary
Cytyc has again extended the expiry date of its offer to buy Digene as the two companies respond to the US Federal Trade Commission's request for further information concerning the acquisition. The expiry date, which had previously been extended to April 11, is now April 25.